Novel Treatments and the Future of DKD: What Is on the Horizon?

Hongju Wu,Vecihi Batuman

DOI: https://doi.org/10.1007/978-3-030-86020-2_28

2022-01-01

Abstract:As diabetes and diabetic kidney disease have reached epidemic proportions across the world, there has been rapid expansion in our knowledge on the immunopathogenesis, genetic and epigenetic mechanisms, and identification of novel therapeutic targets. In this chapter, we will review the major research topics and current developments in the field of diabetes and diabetic kidney disease, which shall provide a perspective on what is on the horizon. Briefly, we will discuss the roles of the immune system in diabetes development and the ongoing research on immunotherapies; we will review the advances in regenerative medicine and nanotechnology for diabetes treatment; we will examine current research on diabetic kidney disease, focusing on the roles of epithelial-to-mesenchymal transition in kidney fibrosis and novel therapeutic targets that may reverse fibrosis; and we will also review current findings in genetic and epigenetic studies, as well as in proteomics and metabolomics research related to diabetic kidney disease. These advancements clearly point to a future in diabetes and diabetic kidney disease with greatly expanded therapy options.